Gattex

Image of a neon sign with the word no lit up next to an unlit yes
Biotech

FDA hits Zealand Pharma's Gattex challenger with CRL

In the FDA’s complete response letter, the agency recommended another clinical trial to provide more data for glepaglutide’s efficacy and safety.
Gabrielle Masson Dec 19, 2024 4:22pm
Nasdaq

Zealand rival to Takeda bowel disease drug hits goal in phase 3

Sep 30, 2022 9:00am